We invite you to order a free bag and binder, which includes a CLL-specific information section and many additional resources to help keep you organized. Bags are available in English and Spanish. Tea It bit.ly/3XhN3E1

New episode alert! Season 2 of CLL Society’s CareCast kicks off with chaplain Rabbi Rebecca Kamil, who shares insights on the emotional & spiritual challenges of living with CLL/SLL. 🎙️ Listen: bit.ly/4cyQYSM and find on Spotify and Apple Music.

Join our webinar on 7/16 at 3:30pm ET with CLL expert Dr. Jennifer Brown. Dr. Brown will discuss novel treatment strategies, combination therapies, & clinical trials for CLL. Fellow CLL patient advocate Terry Evans will moderate. Learn more & register at: bit.ly/3YK3ZoL

CLL Society & @MedScape present a new FREE CME activity for #hematologists, #oncologists & care teams treating relapsed/refractory #CLL/#SLL. ✅ Apply latest guidelines ✅ Personalize treatment plans ✅ Improve outcomes Start learning: bit.ly/4egV3ha

Treatment with ibrutinib-venetoclax produced high rates of uMRD and durable progression-free survival in patients with CLL, irrespective of lymph node size. Learn how this affects long-term survival outcomes. bit.ly/44aORCH

Having a healthcare provider on your team with expertise in CLL can make a significant difference in your treatment journey. Visit the CLL Society website to learn more about what defines a CLL expert and explore our directory to find one near you today. bit.ly/3zfOFqr

As more therapies become available to treat CLL/SLL, healthcare providers are looking for the best way to sequence them. bit.ly/3EMG6FP

Happy Fourth of July! We hope you have a safe and memorable holiday celebrating with family, friends, and loved ones.

Learn how avoiding the freezing of locally produced CAR-T cells improved response rates for relapsed/refractory CLL and Richter’s Syndrome patients treated with an experimental therapy.

Our webinar, Next-Generation CLL Treatments: Understanding Clinical Trials & Future Therapeutic Strategies, is just one week away on July 16! Don't miss this chance to learn about the latest developments in CLL treatment from CLL expert Dr. Jennifer Brown: bit.ly/3YK3ZoL

CAR-T therapy can provide very long remissions in a subset of people with relapsed / refractory CLL who have responded to the treatment for at least one year. bit.ly/3TvLHEF

Choosing the right treatment for CLL can feel overwhelming. Learn how fixed-duration treatments may offer treatment-free periods instead of ongoing therapy Medlive. bit.ly/4iWDch1 #PatientEducation #MedEd

Join CLL Society tomorrow for our webinar Next-Generation CLL Treatments: Understanding Clinical Trials and Future Therapeutic Strategies at 3:30pm ET with CLL expert Dr. Jennifer Brown. Come learn about CLL treatment advancements & clinical trials: bit.ly/3YK3ZoL

Learn more about the CLL therapy combination of zanubrutinib with venetoclax in CLL patients who are being treated for the first time. bit.ly/4lkCafN

People with CLL, treated with ibrutinib, have similar 9-year overall survival to the age-matched general population, irrespective of high-risk features.bit.ly/3TpkmUF

CLL is one of the most common adult leukemias in the U.S. Many are diagnosed without symptoms—but staying informed is key. As Dr. Edward Ratner says, “Being well informed about self-care and treatment options is essential.” bit.ly/45SS6RI

If you are a young person with CLL / SLL and would be interested in joining a CLL Society Support Group for Young People with CLL/SLL, please complete this survey. For the purpose of this group, we define young people as those aged 55 and under. bit.ly/44S08YW

“Cancer is a thief…” — Dr. Brian Koffman shares his personal CLL diagnosis journey in this powerful Verywell Health piece on the emotional toll of cancer. Learn more about the emotional side of cancer and the power of community, compassion, and resilience.bit.ly/4lCg6h2

What are experts Nitin Jain, Krish Patel, & Meghan Thompson saying about sequencing BTKi & BCL2i in CLL & the future of care with next-gen agents? Find out in our new PeerView TownHall, recorded at #ASCO25 & featuring CLL Society. Watch now! bit.ly/3TiuzlO

Announcing CLL Society's Research Awardees: Clinical Scholar: Dr. Matthew S. Davids (Matthew Davids, MD, MMSc) – Dana-Farber Young Investigator: Dr. Quinlan Sievers (Quinn – MSK Integrative Medicine: Dr. Nancy Musoke (Nancy Musoke, MD) – Cleveland Clinic bit.ly/3oXE2CX